GoodRx Holdings, Inc. (GDRX) Costs and Expenses USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
GoodRx Holdings, Inc. quarterly/annual Costs and Expenses history and growth rate from 2019 to 2024.
  • GoodRx Holdings, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $190 M, a 10.3% increase year-over-year.
  • GoodRx Holdings, Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $795 M, a 5.46% increase year-over-year.
  • GoodRx Holdings, Inc. annual Costs and Expenses for 2023 was $777 M, a 1.63% increase from 2022.
  • GoodRx Holdings, Inc. annual Costs and Expenses for 2022 was $765 M, a 4.48% increase from 2021.
  • GoodRx Holdings, Inc. annual Costs and Expenses for 2021 was $732 M, a 11.4% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $795 M $190 M +$17.8 M +10.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $777 M $215 M +$32.6 M +17.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $745 M $218 M +$15.3 M +7.52% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $729 M $171 M -$24.5 M -12.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $754 M $173 M -$10.9 M -5.93% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $765 M $182 M -$19.1 M -9.49% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $784 M $203 M +$14.9 M +7.94% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $769 M $196 M +$18.9 M +10.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $750 M $184 M +$18.1 M +11% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $732 M $202 M -$251 M -55.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $984 M $188 M -$14 M -6.94% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $998 M $177 M +$95.4 M +117% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $902 M $165 M +$75.7 M +84.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $826 M $453 M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $202 M +$138 M +216% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $81.6 M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $89.7 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 $63.9 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.